Categories Health Care, LATEST

Rite Aid (NYSE: RAD) stock soars to 9-month after solid results

Rite Aid Corporation (NYSE: RAD) stock rebounded after better-than-expected earnings results for the third quarter of 2020. The shares soared to a 9-month high of $13.73 in Friday’s early trade.

The stock has fallen over 16% in the past year compared to a 52% decline as of Tuesday. The shares have risen over 64% in the past three months and over 75% in the past six months. During the one-month timeframe, the stock has climbed over 36%.

Till Wednesday, the company has been struggling to recover from the multi-year low on August 27 of $5.04. Rite Aid, which was hurt by the stiff competition, has been making additional investments in the marketing space for acquiring customers in the drugstore industry.

For the third quarter, the pharmacy retailer reported a profit compared to a loss last year, backed by lower costs and expenses as well as gain on debt retirements. The growth in the Medicare Part D membership drove the top line higher by 0.2%. This was hurt by a 1.7% decline in the Retail Pharmacy segment.

The company continues to invest in the expansion and integration of EnvisionRxOptions, particularly its services, technologies, and clinical offerings. The company is pursuing strategic partnerships with health plans and providers as it is on the front lines of healthcare delivery in America.

Read: Avid Bioservices Q2 earnings snapshot

Rite Aid continues to have a focus on owned brand growth and will evolve its owned brand portfolio on the packaging with the goal of redefining its brands in fiscal 2021. Thrifty Ice Cream, which the company recently expanded to 900 additional stores, was a meaningful contributor to its Q3 growth.

Looking ahead into fiscal 2020, the company still expects net sales to be in the range of $21.5 billion to $21.9 billion and annual same-store sales growth in the range of 0-1%. The adjusted EPS guidance is narrowed to the range of $0.13-0.55 from the prior range of $0.00-0.56.

Listen to on-demand earnings calls and hear how management responds to analysts’ questions

Most Popular

Should investors worry about Micron’s (MU) weak Q4 results and guidance?

The semiconductor industry is a rapidly growing business segment that currently thrives on the digital transformation wave. The demand for memory chips and other semiconductor products increased over the years,

What has Bed Bath & Beyond (BBBY) outlined for this fiscal year?

Shares of Bed Bath & Beyond (NASDAQ: BBBY) were up on Friday, a day after the company delivered disappointing results for the second quarter of 2022. The company reported a

NKE Earnings: Highlights of Nike’s Q1 2023 results

Nike, Inc. (NYSE: NKE) has reported a decrease in net profit for the first quarter of 2023, despite a modest increase in revenues. The company's stock suffered a big loss

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top